Kiniksa Pharmaceuticals International, plc (KNSA)

NASDAQ

$78.75

$+0.17

(+0.22%)

Pre-Market

Kiniksa Pharmaceuticals International, plc (KNSA) Live Price Chart

Last updated: ⁦2026-10-14 11:16:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Kiniksa Pharmaceuticals International, plc (KNSA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $78.75, with a market capitalization of $6.18B and a P/E ratio of 75.97. Over the past 52 weeks, its price has ranged from $35.20 to $82.94. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$6.18B
Open	$78.58
Day's High	$82.94
Day's Low	$5.01
Previous Close	$78.53
Volume	8.32K
Average Volume	573.33K
P/E Ratio	75.97
52-Week High	$82.94
52-Week Low	$35.20
Dividend Yield	0.39%
Earnings Date	--

Kiniksa Pharmaceuticals International, plc (KNSA) Pre-Market Stock Price

Kiniksa Pharmaceuticals International, plc (KNSA) is trading at $78.75 in pre-market trading as of 2026-10-14 11:08:00, up 0.28% ($0.22) from the previous close of $78.53

Pre-market trading shows how investors are pricing KNSA before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.

Kiniksa Pharmaceuticals International, plc (KNSA) 7-Day Stock Price Change

Over the past seven days, Kiniksa Pharmaceuticals International, plc (KNSA) moved from $76.31 to $78.75, representing a gain of 3.20% ($2.44).

The stock traded between $73.84 and $80.99 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.

The average daily volume was 416.08 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

KNSA 52-Week Price Position

Position in Range: 91.2%

52W Low$35.20

52W High$82.94

KNSA is currently trading at $78.75, placing it 91.2% of the way from its 52-week low of $35.20 to its 52-week high of $82.94. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Kiniksa Pharmaceuticals International, plc (KNSA)?

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.

Kiniksa Pharmaceuticals International, plc Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	366
Exchange	NASDAQ
Company Website	https://www.kiniksa.com

How to Buy Kiniksa Pharmaceuticals International, plc (KNSA) Stock on MEXC

Eligible investors can buy real shares of Kiniksa Pharmaceuticals International, plc (KNSA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for KNSA and Place Your Order

Open the RealStocks trading page and search for KNSA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Kiniksa Pharmaceuticals International, plc (KNSA) stock price today?

Kiniksa Pharmaceuticals International, plc (KNSA) is currently trading at $ 78.75, up 0.28% ($0.22) from the previous close of $ 78.53. Intraday prices update in real time during regular trading hours.

2.Is KNSA stock going up or down today?

As of 2026-10-14 11:08:00, KNSA is trading at $ 78.75, up 0.28% ($0.22) from its previous close of $ 78.53. The stock has traded between $ 5.01 and $ 82.94 during today’s regular session. Past price movements do not guarantee future results.

3.What is KNSA pre-market price?

As of 2026-10-14 11:08:00, KNSA is trading at $ 78.75 in pre-market trading, up 0.28% ($0.22) from the previous close of $ 78.53. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is KNSA after-hours price?

As of 2026-10-14 11:08:00, KNSA is trading at $ 78.58 in after-hours trading, up 0.06% ($0.05) from the regular-session close of $ 78.53. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is KNSA stock trading now?

KNSA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does KNSA sit relative to its 52-week high and low?

Over the past 52 weeks, KNSA has traded between a low of $ 35.20 and a high of $ 82.94. At $ 78.75, the stock is positioned 91.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Kiniksa Pharmaceuticals International, plc in?

Kiniksa Pharmaceuticals International, plc (KNSA) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Kiniksa Pharmaceuticals International, plc's market capitalization and where is it listed?

Kiniksa Pharmaceuticals International, plc is listed on the NASDAQ exchange with a market capitalization of $ 6.18B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is KNSA valued in terms of P/E ratio and EPS?

KNSA trades at a P/E ratio of 75.97, based on trailing-twelve-month EPS of $ 1.03. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Kiniksa Pharmaceuticals International, plc pay a dividend?

Kiniksa Pharmaceuticals International, plc pays an indicated annual cash dividend of $ 0.31 per share, with a current dividend yield of 0.39% based on the latest share price. Dividend policies are subject to change at the board's discretion.